Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
AI, healthcare technology, and digital infrastructure is a central theme dominating markets: the rapid convergence of AI with data-heavy industries
-
Global Pharmaceutical Microbiology QC Testing Market grows as demand rises for sterility, bioburden, and endotoxin testing in pharmaceutical and biologics.
-
The Stock Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets
-
Totaligent (OTCID: TGNT) signed a binding LOI with GloMed Solutions, a Japanese medical aesthetics and biologics distribution company
-
SAN FRANCISCO and LOS ANGELES and KIGALI, Rwanda, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Bio Usawa, a leader in expanding global access to biopharmaceuticals, and Nanoly Bioscience, a pioneer in chemical...
-
Carterra launches Vega™, the industry’s first 48-channel HT-SPR platform, enabling high-resolution, label-free primary screening for modern drug discovery.
-
Culture Biosciences closed a Series C to scale Stratyx™ 250 and advance its AI-powered Console platform for biologics, cell therapy, and synthetic biology.
-
Ottawa, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The global biologics CDMO market size is expected to hit nearly USD 92.37 billion by 2034, increasing from USD 29.27 billion in 2026, growing at a strong...
-
Xcellbio and Culture Biosciences partner to integrate AVATAR Foundry with Console, enabling real-time data, remote monitoring, and AI-driven optimization.
-
Positioning Barbados as the Caribbean’s Life Sciences Hub: EarlyHealth City to Anchor US$200 Million Investment